Simon is the Founder and Managing Partner of Viopas Venture Consulting, advising health technology and biotech companies on strategy, financing and business development.

Over the past 20 years, Simon was involved in four Private Equity vehicles in healthcare and renewable energy as Managing Partner at Aravis, with combined assets in excess of CHF 250M. These funds invested in over 25 companies, of which 19 were in healthcare; 13 either became public companies (SWX, ATX & NASDAQ) or were acquired.

Simon has extensive experience as a member of Boards of Directors across public and private companies. Among others, he currently serves as Chairman of the Board of Marinomed Biotech AG (ATX-Prime: MARI), and holds Board positions at DyCare, RhyVest AG and Hanaku AG.

Simon holds a Master’s degree and a PhD in structural biology from the Biozentrum, University of Basel, and an MBA from London Business School.